Intranasal Flu Vaccine Shows Promise in Early Trial

(MedPage Today) — An intranasal adjuvanted recombinant influenza vaccine appeared to safely prompt a robust response to a range of H5N1 clades, according to a phase I trial.
Immune responses among the three groups that received one of three doses…